Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 10.


Gorog, Diana A, Gue, Ying X ORCID: 0000-0001-9994-8915, Chao, Tze-Fan, Fauchier, Laurent, Ferreiro, Jose Luis, Huber, Kurt, Konstantinidis, Stavros V, Lane, Deirdre A ORCID: 0000-0002-5604-9378, Marin, Francisco, Oldgren, Jonas
et al (show 7 more authors) (2022) Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. EUROPACE, 24 (11). pp. 1844-1871.


De Caterina, Raffaele, Procopio, Antonio, Lopez Sendon, Jose-Luis, Raev, Dimitar, Mehta, Shamir R, Opolski, Grzegorz, Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626
et al (show 7 more authors) (2020) Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI. AMERICAN JOURNAL OF MEDICINE, 133 (11). pp. 1302-1312.


ten Berg, Jurrien M, Steg, Philippe Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Oldgren, Jonas
et al (show 1 more authors) (2020) Comparison of the Effect of Age (&lt; 75 Versus ≥75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). AMERICAN JOURNAL OF CARDIOLOGY, 125 (5). pp. 735-743.


Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Kimura, Takeshi, Nordaby, Matias, Brueckmann, Martina, Kleine, Eva, ten Berg, Jurrien M, Bhatt, Deepak L
et al (show 1 more authors) (2019) Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. EUROPEAN HEART JOURNAL, 40 (19). 1553-+.


Vamos, Mate, Oldgren, Jonas, Nam, Gi-Byoung, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Calkins, Hugh, Zhu, Jun, Ueng, Kwo-Chang, Ludwigs, Ulf, Wieloch, Mattias, Stewart, John
et al (show 1 more authors) (2022) Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a <i>post hoc</i> analysis of the ATHENA trial. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 8 (4). pp. 363-371.


Zeymer, Uwe, Leiva, Orly, Hohnloser, Stefan H, Steg, Philippe Gabriel, Oldgren, Jonas, Nickenig, Georg, Kiss, Robert Gabor, Ongen, Zeki, Estrada, Jose Navarro, Ophuis, Ton Oude
et al (show 6 more authors) (2021) Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial. EUROINTERVENTION, 17 (6). 474-+.


Schnabel, Renate B ORCID: 0000-0001-7170-9509, Marinelli, Elena Andreassi, Arbelo, Elena, Boriani, Giuseppe, Boveda, Serge, Buckley, Claire M ORCID: 0000-0002-3174-7022, Camm, A John, Casadei, Barbara ORCID: 0000-0002-6801-1617, Chua, Winnie, Dagres, Nikolaos
et al (show 66 more authors) (2023) Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 25 (1). pp. 6-27.


Berry, Natalia C, Mauri, Laura, Steg, Philippe Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Oldgren, Jonas
et al (show 2 more authors) (2020) Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention A Subgroup Analysis From the REDUAL PCI Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 13 (4). e008349-.


Peterson, Benjamin E, Bhatt, Deepak L, Steg, Ph Gabriel, Oldgren, Jonas, Maeng, Michael, Zeymer, Uwe, Halvorsen, Sigrun, Hohnloser, Stefan H, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Kimura, Takeshi
et al (show 5 more authors) (2021) Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial. JACC-CARDIOVASCULAR INTERVENTIONS, 14 (7). pp. 768-780.


Eccleston, David S, Kim, Joseph M, ten Berg, Jurien M, Steg, P Gabriel, Bhatt, Deepak L, Hohnloser, Stefan H, de Veer, Anne, Nordaby, Matias, Miede, Corinna, Kimura, Takeshi
et al (show 3 more authors) (2021) The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials). CLINICAL CARDIOLOGY, 44 (7). pp. 1002-1010.

This list was generated on Sat Apr 20 23:40:37 2024 BST.